Inotek Pharmaceuticals Strengthens Patent Estate for Lead Product Candidate Trabodenoson

by Business Wire • 2016/03/09 • 0 Comments

LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek announced that the United States Patent and Trademark Office (“USPTO”) issued a new composition of matter patent for its lead product candidate, trabodenoson.

← One-year Outcomes Data from Clinical Trial with ReVision Optics’ Raindrop® Near Vision Inlay for Treating Presbyopia Published in Ophthalmology, the Journal of the American Academy of Ophthalmology

Point72 Honored for Health and Wellness Programs by Business Council of Fairfield County →

Post navigation